Skip to main content

The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.

Publication ,  Journal Article
Benatar, M; Sanders, D
Published in: J Neurol Neurosurg Psychiatry
September 2011

Duke Scholars

Published In

J Neurol Neurosurg Psychiatry

DOI

EISSN

1468-330X

Publication Date

September 2011

Volume

82

Issue

9

Start / End Page

945

Location

England

Related Subject Headings

  • Tacrolimus
  • Research Design
  • Randomized Controlled Trials as Topic
  • Prednisone
  • Neurology & Neurosurgery
  • Myasthenia Gravis
  • Interleukin-2
  • Immunosuppressive Agents
  • Humans
  • Biomarkers
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benatar, M., & Sanders, D. (2011). The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis. J Neurol Neurosurg Psychiatry, 82(9), 945. https://doi.org/10.1136/jnnp.2011.243931
Benatar, Michael, and Donald Sanders. “The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.J Neurol Neurosurg Psychiatry 82, no. 9 (September 2011): 945. https://doi.org/10.1136/jnnp.2011.243931.
Benatar M, Sanders D. The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):945.
Benatar, Michael, and Donald Sanders. “The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.J Neurol Neurosurg Psychiatry, vol. 82, no. 9, Sept. 2011, p. 945. Pubmed, doi:10.1136/jnnp.2011.243931.
Benatar M, Sanders D. The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):945.

Published In

J Neurol Neurosurg Psychiatry

DOI

EISSN

1468-330X

Publication Date

September 2011

Volume

82

Issue

9

Start / End Page

945

Location

England

Related Subject Headings

  • Tacrolimus
  • Research Design
  • Randomized Controlled Trials as Topic
  • Prednisone
  • Neurology & Neurosurgery
  • Myasthenia Gravis
  • Interleukin-2
  • Immunosuppressive Agents
  • Humans
  • Biomarkers